CRISPR/Cas9 and other gene-editing technologies are being used at our Lab to precisely modify genes within a patient’s cells to correct mutations that cause disease. This can include knocking out, replacing, or adding genes to correct defects or confer new functions.
Chimeric Antigen Receptor T-cell (CAR-T) Therapy: In CAR-T cell therapy, patient-derived T-cells are genetically modified to express a receptor specific to cancer cells. The lab has the capability for the collection, genetic modification, and expansion of these cells before infusion back into the patient.
Let's Talk
Monday - Friday 800 - 1600